NASDAQ Rheumatology Market News
Mesoblast Cell Therapy Shows Clinical Benefit in First Cohort of Patients With Biologic Refractory Rheumatoid Arthritis
NEW YORK and MELBOURNE, Australia, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) ...
American College of Rheumatology Encourages Safe Adoption of Biosimilars During FDA Public Hearing on CT-P13, a Proposed Biosimilar for Infliximab (Remicade)
ATLANTA, Feb. 10, 2016 (GLOBE NEWSWIRE) -- During a public meeting held Tuesday by ...
EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for BOW015 (Infliximab Biosimilar)
UNIFORMi Study builds on prior successful Phase 1 and Phase 3 studiesIntended to support harmonized ...
pSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results
WATERTOWN, Mass., Feb. 08, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV), (ASX:PVA), a leader ...
Apricus Biosciences to Present at the 18th Annual BIO CEO & Investor Conference
SAN DIEGO, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Emergent BioSolutions Announces Executive Management Team of New Spin-Off Company Aptevo Therapeutics
GAITHERSBURG, Md., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced ...
Apricus Biosciences Announces $10 Million Registered Direct Offering
SAN DIEGO, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Coherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoint in Phase 3 Rheumatoid Arthritis Clinical Study (RaPsODY)
REDWOOD CITY, Calif., and BANNOCKBURN, Ill., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS) and Baxalta ...
Mannkind Announces Addition of Chief Medical Officer
VALENCIA, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced the ...
Crescendo Bioscience Names Elena Hitraya M.D., Ph.D., as Chief Medical Officer
SALT LAKE CITY, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary ...
Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Italy by Bracco SpA
To Be Commercialized in Italy as Vitaros® SAN DIEGO, Sept. 1, 2015 (GLOBE NEWSWIRE) -- ...
The Lupus Initiative Launches National Program to Develop Transformative Care Model; Embarks On Initiative with Collaborative Partners to Expand Lupus Health Care Access to Underserved Populations
The ACR's The Lupus Initiative offers sorely needed education to health providers, while improving ...
Allscripts Ambulatory/ Alternate Site Solutions Ranked No. 1 by Black Book(TM) Rankings
CHICAGO, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) earned top scores for its ...